Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Real-World Data Could Get Boost From Trial Replication Project

Apr 27 2018

• By Derrick Gingery

Yellow road sign with a blue sky and white clouds: clinical trial

Related Content

Real World Evidence Benefits, Limits Explored In US FDA Demonstrations

Oct 30 2017

Clinical Trial System 'Broken,' But Modernization Long Way Away – Woodcock

Sep 21 2017

US FDA Officials Provide Primer On 'Real-World' Data

Sep 01 2017

New CDER No. 2 May Impact FDA's Safety Monitoring Aspirations

Apr 18 2018

Opioid Use Disorder: Is Reduced Usage A Better Endpoint Than Abstinence?

Apr 24 2018

From Listening To Advising: The Maturation Of US FDA's Patient-Focused Drug Development Program

Jan 09 2018

FDA’s Next Step to Real-World Evidence: Prove That Real-World Studies Can Match Known RCT Results

Mar 29 2016

The Evolution Of 21<sup>st</sup> Century Cures Legislation

Nov 30 2016

Additional Topics

United States Clinical Trials Regulation FDA BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window